文献速递自身炎症与 IgG4 相关病

中国成人NLRP3相关自身炎症性疾病伴听力损失患者的表型与基因型特征

Phenotypic and genotypic characterization of Chinese adult patients with NLRP3-associated autoinflammatory disease with hearing loss.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

北京协和医院2015年7月至2023年3月回顾性纳入21例成人NLRP3相关自身炎症性疾病(NLRP3-AID)患者,全部接受全外显子测序和耳鼻喉评估。13/21(61.90%)存在听力损失,多数为高频受损,多数伴前庭功能障碍;早发、冷或应激诱发、红眼、乏力、视力下降及NLRP3蛋白NACHT结构域突变者更易出现听力损失,尤其感音神经性听力损失。TNF-α抑制剂被证实可改善或逆转听力损失。

要点

  • 21例成人NLRP3-AID中13/21(61.90%)有听力损失,多数为高频受损。
  • 多数患者伴前庭功能障碍,为新发现。
  • 早发、冷或应激诱发、红眼、乏力、视力下降及NACHT结构域突变者更易出现听力损失。

核心结论

  • 本文报告了首个中国成人NLRP3-AID伴听力损失队列,并描述了前庭功能障碍,强调关注高频听力,提供了潜在替代治疗。

研究设计与样本

  • 回顾性队列研究,纳入2015年7月至2023年3月北京协和医院21例成人NLRP3-AID患者,全部行全外显子测序和耳鼻喉科评估,收集临床与治疗资料。

主要发现

  • 13/21(61.90%)患者存在听力损失,多数为高频受损。
  • 多数患者表现为前庭功能障碍,为新发现。
  • 早发、冷或应激诱发发作、红眼、乏力、视力下降及NLRP3蛋白NACHT结构域突变的NLRP3-AID患者更易发生听力损失,尤其感音神经性听力损失,可能源于高外显率致病性变异。
  • 通过系列听力学评估,TNF-α抑制剂被证实可改善或逆转听力损失。

关键数值与推荐

  • 听力损失定义为13/21(61.90%)患者存在听力损失,多数为高频受损。
  • 多数患者存在前庭功能障碍。
  • 早发、冷或应激诱发发作、红眼、乏力、视力下降及NACHT结构域突变与听力损失(尤其感音神经性听力损失)相关。
  • TNF-α抑制剂被证实可改善或逆转听力损失。

临床怎么用

  • 作者强调需关注NLRP3-AID患者的高频听力,并指出TNF-α抑制剂为潜在替代治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Nucleotide-binding oligomerization domain-like receptor family, pyrin domain containing 3-associated autoinflammatory disease (NLRP3-AID) is a rare autosomal dominant systemic autoinflammatory disease. We aimed to summarize the phenotypic and genotypic features of Chinese adult NLRP3-AID patients with hearing loss. METHODS: A retrospective cohort study of twenty-one adult patients with NLRP3-AID was conducted in Peking Union Medical College Hospital between July 2015 and March 2023. All patients underwent whole exome sequencing and otorhinolaryngologic assessments. Clinical features and therapeutic data were collected and analysed. RESULTS: We found that 13/21 (61.90%) of patients had hearing loss with high-frequency impairment in the majority, and most patients presented with vestibular dysfunction as a new finding. The NLRP3-AID patients with early-onset, cold or stress triggered episodes, red eyes, fatigue, hypopsia and mutations located in the NACHT domain of the NLRP3 protein were more likely to suffer from hearing loss, especially sensorineural hearing loss, perhaps as a result of pathogenic variants of high penetrance. By a series of audiological evaluations, TNF-α inhibitors were confirmed to improve or reverse hearing loss. CONCLUSIONS: We reported the first cohort of Chinese adult NLRP3-AID patients with hearing loss and characterized vestibular dysfunction, highlighted the necessity for attention to high-frequency hearing and provided potential alternative treatment.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wu B, Luo Y, Wu D, et al. Phenotypic and genotypic characterization of Chinese adult patients with NLRP3-associated autoinflammatory disease with hearing loss. Rheumatology (Oxford). 2024. PMID: 37656934. doi:10.1093/rheumatology/kead451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。